Figure 3.

At T₀ (baseline), COL/ADP induced closure times were not significantly different between the three groups. Immediately after the administration of either abciximab or high-dose tirofiban (T₁), the PFA-100 CADP closure time was significantly prolonged compared with its baseline value (T₀). No differences were seen in CADP closure time values between the two GP IIb/IIIa inhibitor treated groups at time points T₁ and T₄ (p=0.33 at T₁ and p=1.0 at T₄). *The CADP closure times were significantly prolonged in both GP IIb/IIIa inhibitor treated groups as compared with the control group at time points T₁ (p=0.006) and T₄ (p<0.0001).